Dezamizumab is under investigation in clinical trial NCT03417830 (Biodistribution of 89Zirconium-labelled GSK2398852 Using PET Imaging).
Alpha Lifetech is proud to offer biosimilar antibodies product, Dezamizumab Biosimilar, designed to revolutionize the treatment of various research conditions. Our Dezamizumab Biosimilar antibody product is manufactured using biotechnological processes, ensuring high purity, potency, and consistency in every batch. The development of a dezamizumab biosimilar requires a comprehensive approach to demonstrate similarity to the reference product in terms of quality, safety, and efficacy. Choose Alpha Lifetech’s biosimilar antibody product for a reliable, effective, and cost-efficient treatment solution.